[
Journal
Neurology
ISSN: 1526-632X
Titre abrégé: Neurology
Pays: United States
ID NLM: 0401060
Informations de publication
Date de publication:
07 11 2023
07 11 2023
Historique:
received:
07
06
2023
accepted:
17
07
2023
pmc-release:
07
11
2024
medline:
8
11
2023
pubmed:
26
9
2023
entrez:
25
9
2023
Statut:
ppublish
Résumé
Translocator protein 18 kDa (TSPO) PET imaging is used to monitor glial activation. Recent studies have proposed TSPO PET as a marker of the epileptogenic zone (EZ) in drug-resistant focal epilepsy (DRFE). This study aims to assess the contributions of TSPO imaging using [ We compared [ The study included 23 patients. Visual analysis of [ [ Eudract 2017-003381-27. Inclusion of the first patient: September 24, 2018. This study provides Class IV evidence on the utility of [
Sections du résumé
BACKGROUND AND OBJECTIVES
Translocator protein 18 kDa (TSPO) PET imaging is used to monitor glial activation. Recent studies have proposed TSPO PET as a marker of the epileptogenic zone (EZ) in drug-resistant focal epilepsy (DRFE). This study aims to assess the contributions of TSPO imaging using [
METHODS
We compared [
RESULTS
The study included 23 patients. Visual analysis of [
DISCUSSION
[
TRIAL REGISTRATION INFORMATION
Eudract 2017-003381-27. Inclusion of the first patient: September 24, 2018.
CLASSIFICATION OF EVIDENCE
This study provides Class IV evidence on the utility of [
Identifiants
pubmed: 37748889
pii: WNL.0000000000207811
doi: 10.1212/WNL.0000000000207811
pmc: PMC10663012
doi:
Substances chimiques
N,N-diethyl-2-(2-(4-(2-fluoroethoxy)phenyl)-5,7-dimethylpyrazolo(1,5-a)pyrimidin-3-yl)acetamide
0
Fluorodeoxyglucose F18
0Z5B2CJX4D
TSPO protein, human
0
Receptors, GABA
0
Banques de données
EudraCT
['2017-003381-27']
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
e1893-e1904Informations de copyright
© 2023 American Academy of Neurology.
Références
Seizure. 2017 Jan;44:42-47
pubmed: 27884611
J Nucl Med. 2012 Feb;53(2):234-40
pubmed: 22238156
Epilepsia. 2019 Jun;60(6):1248-1254
pubmed: 31144767
Epilepsia. 2012 Aug;53(8):1333-40
pubmed: 22709127
J Cereb Blood Flow Metab. 1996 Sep;16(5):834-40
pubmed: 8784228
Eur J Nucl Med Mol Imaging. 2021 Dec;49(1):257-268
pubmed: 33779770
J Nucl Med. 2008 May;49(5):814-22
pubmed: 18413395
Epilepsia. 2009 Sep;50(9):2147-53
pubmed: 19389145
J Cereb Blood Flow Metab. 2012 Jan;32(1):1-5
pubmed: 22008728
J Cereb Blood Flow Metab. 2018 Feb;38(2):333-346
pubmed: 28178885
J Nucl Med. 2016 Dec;57(12):1927-1932
pubmed: 27339875
Epilepsia. 2000 Oct;41(10):1350-6
pubmed: 11051134
J Nucl Med. 2015 Jul;56(7):1048-54
pubmed: 26025960
Brain. 2016 Apr;139(Pt 4):1252-64
pubmed: 26984188
Hum Brain Mapp. 2003 Aug;19(4):224-47
pubmed: 12874777
Ann Neurol. 1992 Dec;32(6):789-94
pubmed: 1471870
Neurology. 2010 Dec 14;75(24):2168-75
pubmed: 21172840
Parkinsonism Relat Disord. 2021 Jan;82:29-36
pubmed: 33242662
J Neuroimaging. 2013 Jan;23(1):129-31
pubmed: 21223436
Epilepsia. 1998 Dec;39(12):1375-6
pubmed: 9860078
EJNMMI Res. 2012 Nov 08;2(1):60
pubmed: 23136853
JAMA Neurol. 2015 Aug;72(8):882-8
pubmed: 26052981
Radiology. 2021 Oct;301(1):166-177
pubmed: 34254858
Eur J Nucl Med Mol Imaging. 2021 Dec;49(1):221-233
pubmed: 34120191
Eur J Nucl Med Mol Imaging. 2021 Dec;49(1):146-163
pubmed: 33433698
Neurology. 1999 Dec 10;53(9):2199-203
pubmed: 10599809
J Nucl Med. 2015 May;56(5):701-6
pubmed: 25766898
Eur J Nucl Med Mol Imaging. 2021 Dec;49(1):246-256
pubmed: 33693967
Epilepsia. 2022 May;63(5):1238-1252
pubmed: 35166379
Brain. 2004 Jan;127(Pt 1):164-74
pubmed: 14534161
Nat Rev Neurol. 2019 Oct;15(10):594-606
pubmed: 31341275
Epilepsy Res Treat. 2012;2012:201651
pubmed: 22934162
Epilepsia. 2016 Sep;57(9):e191-4
pubmed: 27381590
Brain. 2018 Jun 1;141(6):1855-1870
pubmed: 29608645
J Nucl Med. 2009 Mar;50(3):468-76
pubmed: 19223401
Ann Neurol. 2020 Sep;88(3):477-488
pubmed: 32542728
N Engl J Med. 2011 Sep 8;365(10):919-26
pubmed: 21899452
J Neuroinflammation. 2021 Jan 6;18(1):8
pubmed: 33407581